Estimated read time: 4-5 minutes KEY TAKEAWAYS

Pharmaceutical company AstraZeneca sues Utah over SB69, claiming it contradicts federal drug pricing laws.

The company argues SB69 unlawfully expands the Section 340B drug discount program, violating the supremacy clause.

AstraZeneca seeks a halt on the law's enforcement, citing financial harm and reputational damage.

SALT LAKE CITY — The pharmaceutical drug company AstraZeneca filed a lawsuit against the Utah attorney general, claiming Utah's new law on limiting prescription drug prices goes against a federal health care program and would cost the company millions of dollars.

A federal discount drug program was established in 1992 by Section 340B of the federal Public Health Service Act. It requires pharmaceutical manufacturers that p

See Full Page